Abstract

 

Epilepsy in Latin America

 

Li Min Li, MD, PhD; Marilisa M. Guerreiro, MD, PhD; Carlos A.M. Guerreiro, MD, PhD; Fernando Cendes, MD, PhD.

 

Epilepsy is a common chronic neurological condition with a prevalence of ~1%.  According to a survey by International League Against Epilepsy, ~85% of all patients with epilepsy live in developing countries.  Fifty percent of patients had onset of their seizures in childhood.  It is estimated that 5,000,000 people in Latin America and the Caribbean have epilepsy, of those 3,500,000 are not treated.  Parasitic infections and poor prenatal and perinatal care figure as causes of epilepsy, and can explain a higher incidence of epilepsy in some countries in Latin America.  The current health system in Brazil was unified by a law passed on September 19, 1990, creating the Unified Health System [Sistema Único de Saúde (SUS)].  The total expenditures in health care in Brazil in 2000 was around R$ 230-240 (US$ 134) “per capita”, R$ 170-180 were from the federal and R$ 60-70 from the city and state expenditures.  SUS theoretically offers total coverage but in reality, SUS covers about 77% of the whole population.  Of these, 22% do no receive medical assistance (~34 million), and another 55% receive some type of assistance (~86 million).  The remaining 23% (~36 million) seek the private sector for assistance, which can be: medical insurance, health maintenance organizations (HMOs), private medicine, and others.  The supply of anti-epileptic medication (AED) by SUS is not regular or well distributed in Brazil.  In general, phenobarbital is regularly supplied, phenytoin and carbamazepine are irregularly supplied, and valproate is not supplied by SUS.  The lack of proper AED treatment contributes to the overall stigmatization of patients with epilepsy.  In addition, the laymen’s knowledge of epilepsy is very unsatisfactory.  The high rate of illiteracy and low cultural standards help to perpetuate the old prejudices against epilepsy.  A comprehensive educational effort to inform the patient and his environment about epilepsy and adequate treatment are basic steps in a successful management of this condition.